当前位置：首页 > 文献互助 > 互助详情

期刊论文Antibody–Drug Conjugates: The Past, Present and Future复制

用户nVQ8vMo0sTW0 1个月前 77 已完结

1. 系统已在2026-03-31 16:11:46对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1146/annurev-cancerbio-070524-032954复制

文献链接: https://www.annualreviews.org/content/journals/10.1146/annurev-cancerbio-070524-032954复制

其他信息:

出版社: Annual Reviews
作者: Gail D. Lewis

上一篇：Antibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions

下一篇：Discovery of YYSW001: A Highly Selective, Orally Bioavailable JAK1 Inhibitor Achieving Efficacy under a Moderate-Inhibition Strategy with Improved Preclinical Tolerability

互助时间线

2026-03-26 20:41:51 [完结求助]

系统完结了求助, 已自动确认了旅行者2023应助的文件是正确的, 求助状态变成已完结

2026-03-24 16:11:46 [上传文件]

旅行者2023上传了文件(pdf 502.32 KB), 求助状态变成待确认

2026-03-21 20:41:51 [发起求助]

最新发布的求助

Social media analysts, investor attention, and IPO underpricing 3小时前

How does sponsor Co-investment distort institutional investor bidding? Evidence from China 3小时前

Information quality and IPO underpricing: The role of underwriter pricing and allocation powers 3小时前

How does sponsor Co-investment distort institutional investor bidding? Evidence from China 3小时前

The JOBS Act and Information Uncertainty in IPO Firms American Accounting Association 3小时前

Venture capitalist quality and IPO certification 3小时前

How does knowledge affect IPO pricing? A new approach grounded in the knowledge-based view 3小时前

Information spillover in Chinese hybrid IPO auctions 3小时前

Navigating the Methodological Frontier in Capital Market Research 4小时前

The JOBS Act and Information Uncertainty in IPO Firms 4小时前

The JOBS Act and Information Uncertainty in IPO Firms 4小时前

HTRA1 macrophages induce T cells egress through CRIP1/NF-κB/CXCL12 to limit the effects of immunotherapy in triple-negative breast cancer 6小时前